TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 SEK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
1,308
|
1,027
|
1,220 |
| Financial expenses |
32
|
37
|
16 |
| Earnings before taxes |
89
|
-73
|
-109 |
| EBITDA |
183
|
14
|
-93 |
| Total assets |
416
|
488
|
450 |
| Current assets |
85
|
95
|
121 |
| Current liabilities |
214
|
375
|
265 |
| Equity capital |
202
|
113
|
185 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
48.6%
|
23.2%
|
41.1% |
| Turnover per employee |
1,308
|
1,027
|
1,220 |
| Profit as a percentage of turnover |
6.8%
|
-7.1%
|
-8.9% |
| Return on assets (ROA) |
29.1%
|
-7.4%
|
-20.7% |
| Current ratio |
39.7%
|
25.3%
|
45.7% |
| Return on equity (ROE) |
44.1%
|
-64.6%
|
-58.9% |
| Change turnover |
281
|
-193
|
-762 |
| Change turnover % |
27%
|
-16%
|
-38% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.